"Current clinical guidelines for identifying methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission are resulting in 30 times more patients with pneumonia being treated with anti-MRSA drugs than theoretically necessary bec"...
(human IgG1λ monoclonal antibody) for Intravenous Infusion
Raxibacumab is a human IgG1λ monoclonal antibody that binds the PA component of B. anthracis toxin. Raxibacumab has a molecular weight of approximately 146 kilodaltons. Raxibacumab is produced by recombinant DNA technology in a murine cell expression system.
Raxibacumab is supplied as a sterile, liquid formulation in single-dose vials for intravenous infusion. Each vial contains 1,700 mg/34 mL (50 mg/mL) raxibacumab in citric acid (0.13 mg/mL), glycine (18 mg/mL), polysorbate 80 [0.2 mg/mL (w/v)], sodium citrate (2.8 mg/mL), and sucrose (10 mg/mL), with a pH of 6.5. Raxibacumab is a clear to opalescent, colorless to pale yellow, liquid.
Last reviewed on RxList: 2/11/2016
This monograph has been modified to include the generic and brand name in many instances.
Additional Raxibacumab Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.